Richard M Nixon

Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choice

James R Carpenter, Karla Diaz-Ordaz, Richard Grieve, 2016, Statistical methods in medical research.

Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations.

Simon G Thompson, Richard M Nixon, S. Thompson, 2005, Health economics.

Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis.

Alan Brennan, Nick Bansback, Kaleb Michaud, 2008, Arthritis and rheumatism.

Estimating the rates of disability progression in people with active relapsing-remitting multiple sclerosis

Richard M Nixon, R. Gani, R. Nixon, 2007 .

Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension

Richard M Nixon, Gorana Capkun, R. Nixon, 2015, BMC Medical Research Methodology.

The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation

Anthony O'Hagan, Jason Madan, Alan Brennan, 2009, Pharmaceutical statistics.

Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study.

Richard Grieve, Simon G Thompson, Richard M Nixon, 2006, Journal of health economics.

How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions?

Simon G Thompson, Richard M Nixon, S. Thompson, 2005, Medical decision making : an international journal of the Society for Medical Decision Making.